The Limited Times

Now you can see non-English news...

WHO: 'We need new vaccines, boosters with current ones are not enough'

2022-01-11T18:04:09.662Z

'They must have a high impact on the prevention of infection (Photon and transmission'. Ema: 'No data to support the second booster' (ANSA)



"Covid-19 vaccines that have a high impact on the prevention of infection and transmission, as well as the prevention of severe disease and death, are needed and should be developed." The experts of the World Health Organization affirm this, according to which against the emergence of new variants it is not useful to continue to carry out boosters with already existing vaccines. "A vaccination strategy based on repeated boosters" of current vaccines "has little chance of being appropriate or sustainable," WHO explains. "While waiting for these" new "vaccines to be available, and in the light of the evolution of the SARS-CoV-2 virus, it may be necessary to update the composition of the current anti-Covid vaccines,to ensure they continue to provide the WHO-recommended level of protection against infection and disease "caused by the variants, the experts add.

Ema, no data to support the second booster

 - "A discussion is emerging on the possibility of administering a second booster dose with the same vaccines currently in use: no data have yet been generated to support this approach." The head of the vaccination strategy of the European Medicines Agency (EMA), Marco Cavaleri, said at a press conference. "If the use of boosters could be considered part of a contingency plan, repeated vaccinations at short intervals would not be a sustainable long-term strategy," he noted.

Omicron "is fast becoming the dominant variant"

and "appears to cause a less severe infection but more data is needed." The head of the vaccination strategy of the European Medicines Agency (EMA), Marco Cavaleri, said at a press conference. Omicron, he added, is "a potential burden for hospitals" so it "should not be underestimated".

"Pregnant women are more likely to get seriously ill with Covid-19 than non-pregnant women

, but the new vaccine data are very reassuring and show that they reduce the risk of hospitalization and death during pregnancy without causing complications or harming the unborn child. ". The head of the vaccination strategy of the European Medicines Agency (EMA), Marco Cavaleri, said at a press conference.

The approval of the European Medicines Agency (EMA) for vaccines adapted to deal with the Omicron variant could arrive "in April-May"

.

This was stated by the head of the Ema vaccination strategy, Marco Cavaleri, responding to a question from ANSA, specifying that it is still necessary to analyze whether a "global discussion" on new doses is necessary and whether "pursuing the virus instead of anticipating it" is "the right strategy in the interest of public health".

Source: ansa

All life articles on 2022-01-11

You may like

News/Politics 2022-03-27T01:17:06.361Z
News/Politics 2022-02-22T11:04:06.772Z

Trends 24h

Life/Entertain 2022-05-18T12:53:09.727Z
Life/Entertain 2022-05-17T17:50:55.196Z

Latest

© Communities 2019 - Privacy